Investing in Medical Nanotechnologies Conference
11/8/2006 1:50:07 PM
Are you a new company commercializing medical nanotechnologies?
Do you see nano and micro companies as a key market for your business?
Do you want to know who is developing the cutting-edge medical technologies?
Are you a nano and micro company looking for a major investment?
Are you an investor seeking new opportunities?
Nanomednet's Investing in Medical Nanotechnologies Conference will showcase cutting edge technologies in personalized medicine, targeted drug delivery, nanobiomaterials, regenerative medicine, analytical and diagnostic techniques, body-friendly implants, imaging techniques, treatments for degenerative diseases, cures for diseases for the aging population, functionalised nanoparticles, and converging technologies for healthcare applications.
International keynote speakers include:
Prof. Sir Michael Rawlins, Chairman, National Institute of Clinical Excellence, UK
Dr. Paul Smit, Senior Vice President, Philips Medical Systems
Dr. Leonard Fass, Director, Academic Relations, GE Healthcare
Dr Philippe Cleuziat, Technological Marketing Director, Biomerieux
Mr. Kim Kreilgaard, Head of Division, European Investment Bank
Dr Thomas. K. Epprecht, Senior Risk Specialist, Swiss Reinsurance Company
Dr. Ogan Gurel, CEO, Duravest inc
Dr. Arne Hengerer, Director, Molecular MRI, Siemens Medical Solutions
Venue: The Royal Garden Hotel, London: For a Central London event, The Royal Garden Hotel is the closest five-star luxury hotel to Heathrow. It is outside London's congestion charge zone. The ECP car park underneath the property offers space for up to 160 vehicles.
Programme: nanomednet.org
Register: nanomednet.org |
